34 related articles for article (PubMed ID: 6664356)
1. The use of skinfold measurements to judge obesity during the early phase of Prader-Labhart-Willi syndrome.
Butler MG; Butler RI; Meaney FJ
Int J Obes; 1988; 12(5):417-22. PubMed ID: 3235262
[TBL] [Abstract][Full Text] [Related]
2. An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome.
Butler MG; Meaney FJ
Am J Med Genet; 1987 Feb; 26(2):445-55. PubMed ID: 3812595
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Obesity in the Prader-Labhart-Willi Syndrome: Fatness Patterning.
Meaney FJ; Butler MG
Med Anthropol Q; 1989 Sep; 3(3):294-305. PubMed ID: 27695159
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial variation and growth in the Prader-Labhart-Willi syndrome.
Meaney FJ; Butler MG
Am J Phys Anthropol; 1987 Dec; 74(4):459-64. PubMed ID: 3442297
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretion in Prader-Willi syndrome.
Grosso S; Cioni M; Buoni S; Peruzzi L; Pucci L; Berardi R
J Endocrinol Invest; 1998; 21(7):418-22. PubMed ID: 9766254
[TBL] [Abstract][Full Text] [Related]
6. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance.
Eiholzer U; Gisin R; Weinmann C; Kriemler S; Steinert H; Torresani T; Zachmann M; Prader A
Eur J Pediatr; 1998 May; 157(5):368-77. PubMed ID: 9625332
[TBL] [Abstract][Full Text] [Related]
7. Prader-Willi syndrome: current understanding of cause and diagnosis.
Butler MG
Am J Med Genet; 1990 Mar; 35(3):319-32. PubMed ID: 2309779
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
9. [Prader-Labhart-Willi syndrome].
Fesseler WH; Bierich JR
Monatsschr Kinderheilkd; 1983 Dec; 131(12):844-7. PubMed ID: 6664356
[TBL] [Abstract][Full Text] [Related]
10. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
Schmidt H; Bechtold S; Schwarz HP
Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
[TBL] [Abstract][Full Text] [Related]
11. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE
Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
14. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
